ConductScience.org, home

Paper3987552

Vascular selectivity of felodipine.

Ljung B. Drugs, 1985. Cited by 238 papers, by iCite.

Cite this record

ConductScience Library. Vascular selectivity of felodipine. Papers, record 3987552. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3987552

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Vascular selectivity of felodipine.
PubMed
Journal
Drugs
PubMed
Year
1985
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
238
iCite
Relative citation ratio, by iCite
12.7
iCite
Revised in PubMed
2018-11-13
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ljung BB

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antihypertensive AgentsMajor topic
HemodynamicsMajor topic
NifedipineMajor topic
Animals
Calcium Channel Blockers
Dogs
Felodipine
Heart
In Vitro Techniques
Male
Muscle Contraction
Muscle, Smooth, Vascular
Myocardial Contraction
Rats
Rats, Inbred Strains
Species Specificity
Vascular Resistance

Source PubMed

Download CSV of topics

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1886659Effects of calcium-antagonistic coronary vasodilators on myocardial contractility and membrane potentials.Jpn J Pharmacol1977https://conductscience.org/library/papers/886659PubMed
23987556Acute haemodynamic effects of felodipine in patients with coronary artery disease.Drugs1985https://conductscience.org/library/papers/3987556PubMed
33987558Haemodynamic effects of short and long term administration of felodipine in spontaneously hypertensive rats.Drugs1985https://conductscience.org/library/papers/3987558PubMed
47378928Calcium antagonistic drugs. Mechanism of action.Can J Physiol Pharmacol1980https://conductscience.org/library/papers/7378928PubMed
54631469Pharmacologic properties of minoxidil: a new hypotensive agent.J Pharmacol Exp Ther1973https://conductscience.org/library/papers/4631469PubMed
63987545Effects of felodipine on renal function in animals.Drugs1985https://conductscience.org/library/papers/3987545PubMed
77357211Some effects of sodium nitroprusside, methoxyverapamil (D600) and nifedipine on rat portal vein.Br J Pharmacol1980https://conductscience.org/library/papers/7357211PubMed
87266647Interaction of the antihypertensive drug felodipine with calmodulin.Nature1981https://conductscience.org/library/papers/7266647PubMed
94623697
[Electromechanical uncoupling of vascular smooth muscle as the basic principle of coronary dilatation by 4-(2'-nitrophenyl-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester (BAY a 1040, Nifedipine). 1. The significance of Ca ++ ions for the bioelectrical and mechanical activity of smooth muscle].
Arzneimittelforschung1972https://conductscience.org/library/papers/4623697PubMed
106633675Cardiovascular actions of the calmodulin inhibitor felodipine.Naunyn Schmiedebergs Arch Pharmacol1983https://conductscience.org/library/papers/6633675PubMed
117252845The mechanism of inhibitory action of diltiazem on vascular smooth muscle contractility.J Pharmacol Exp Ther1981https://conductscience.org/library/papers/7252845PubMed
1214206315DESCRIPTION OF THE MYOGENIC HYPOTHESIS.Circ Res1964https://conductscience.org/library/papers/14206315PubMed
136202978Effect of felodipine, a new dihydropyridine vasodilator, on contractile responses to potassium, noradrenaline, and calcium in mesenteric resistance vessels of the rat.J Cardiovasc Pharmacol1984https://conductscience.org/library/papers/6202978PubMed
1414207247ELECTRICAL AND MECHANICAL ACTIVITY OF ISOLATED VASCULAR SMOOTH MUSCLE OF THE RAT.Nature1964https://conductscience.org/library/papers/14207247PubMed
156772384Studies with isolated human coronary arteries. Some general observations, potential mediators of spasm, role of calcium antagonists.Chest1980https://conductscience.org/library/papers/6772384PubMed
167060638Calcium antagonist receptor binding sites labeled with [3H]nitrendipine.Eur J Pharmacol1982https://conductscience.org/library/papers/7060638PubMed
176875846Calcium and calmodulin antagonists binding to calmodulin and relaxation of coronary segments.J Pharmacol Exp Ther1983https://conductscience.org/library/papers/6875846PubMed
182859183Antihypertensive effects of felodipine compared with placebo.Drugs1985https://conductscience.org/library/papers/2859183PubMed
197225259Nifedipine and left ventricular function in beta-blocked patients.Br Heart J1981https://conductscience.org/library/papers/7225259PubMed
20906865Dependence on external calcium for the noradrenaline contractility of the resistance vessels in spontaneously hypertensive and renal hypertensive rats, as compared with normotensive controls.Acta Physiol Scand1977https://conductscience.org/library/papers/906865PubMed

See all 25 referencesDownload CSV of references

Cited by66

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 238 citations.

PMIDTitleJournalYearIn PapersSource
41708546Enhanced Oral Bioavailability of Felodipine via Solid Self-microemulsion Delivery System.AAPS PharmSciTech2026https://conductscience.org/library/papers/41708546PubMed
9646008Clinical pharmacokinetics of vasodilators. Part I.Clin Pharmacokinet1998https://conductscience.org/library/papers/9646008PubMed
8842509Beneficial effects of felodipine on myocardial and coronary function during low-flow ischemia and reperfusion.Cardiovasc Drugs Ther1996https://conductscience.org/library/papers/8842509PubMed
8665991Clinical equivalence of two tablet formulations of felodipine. A placebo-controlled study of 24-hour blood pressure control and tolerability.Eur J Clin Pharmacol1995https://conductscience.org/library/papers/8665991PubMed
8573548Vascular selective calcium entry blockers in the treatment of cardiovascular disorders: focus on felodipine.Cardiovasc Drugs Ther1995https://conductscience.org/library/papers/8573548PubMed
8321836Absorption, gastrointestinal transit, and tablet erosion of felodipine extended-release (ER) tablets.Pharm Res1993https://conductscience.org/library/papers/8321836PubMed
8299664The acute haemodynamic and renal effects of oral felodipine and ramipril in healthy subjects.Eur J Clin Pharmacol1993https://conductscience.org/library/papers/8299664PubMed
8241007Hypertension in the elderly: age- and disease-related complications and therapeutic implications.Cardiovasc Drugs Ther1993https://conductscience.org/library/papers/8241007PubMed
7742263Efficacy and tolerability of felodipine ER and diltiazem SR as monotherapy in primary hypertension: a double-blind randomized study.Cardiovasc Drugs Ther1994https://conductscience.org/library/papers/7742263PubMed
7720759Natriuretic and diuretic effects of felodipine and hydrochlorothiazide after single and repeated doses.Eur J Clin Pharmacol1995https://conductscience.org/library/papers/7720759PubMed
7523061Vascular versus myocardial effects of calcium antagonists.Drugs1994https://conductscience.org/library/papers/7523061PubMed
3912182Felodipine in hypertension.Eur J Clin Pharmacol1985https://conductscience.org/library/papers/3912182PubMed
3582465Acute renal effects of oral felodipine in normal man.Eur J Clin Pharmacol1987https://conductscience.org/library/papers/3582465PubMed
3519241Treatment of essential hypertension with felodipine in combination with a diuretic.Eur J Clin Pharmacol1986https://conductscience.org/library/papers/3519241PubMed
3443068Haemodynamic effects of felodipine in congestive heart failure.Drugs1987https://conductscience.org/library/papers/3443068PubMed
3443064Metabolism of [14C] felodipine, a new vasodilating drug, in healthy volunteers.Drugs1987https://conductscience.org/library/papers/3443064PubMed
3443063Pharmacokinetics of felodipine and effect on digoxin plasma levels in patients with heart failure.Drugs1987https://conductscience.org/library/papers/3443063PubMed
3443060Antihypertensive and biochemical effects of the dihydropyridine felodipine in the long term treatment of moderate to severe hypertension.Drugs1987https://conductscience.org/library/papers/3443060PubMed
3443058Comparison of antihypertensive effect and pharmacokinetics of conventional and extended release felodipine tablets in patients with arterial hypertension.Drugs1987https://conductscience.org/library/papers/3443058PubMed
3405320Restoration of renal and mesenteric hemodynamics by felodipine in a canine model of hemorrhagic shock.Naunyn Schmiedebergs Arch Pharmacol1988https://conductscience.org/library/papers/3405320PubMed

See all 66 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3987552

GET https://conductscience.org/api/papers/v1/3987552/references?page=2